Dan Capon, PhD
Visiting Scientist, Blood Systems Research Institute

Dr. Capon is the co-inventor of several of biotech’s leading products and technologies, including Fc fusion proteins (Genentech), recombinant Factor VIII for hemophilia (Genentech), XenoMouse for fully human antibodies (Abgenix), the PhenoSense HIV drug resistance test (Monogram Biosciences), and Chimeric Antigen Receptors for T cell immunotherapy (Cell Genesys). He holds 43 US patents, which have been licensed for a number of biotech blockbuster drugs, including Enbrel, Kogenate, Vectibix and Xgeva, representing over $12 billion in annual sales.